Physician profile
Beth Steinfeld
NPI 1679899876
$3,022.30
in general payments reported to CMS, 2019-2025
20 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 97% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $431 · 2023: $392 · 2024: $677 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,259.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $677.73 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $349.34 | 2023-2025 | Myfembree |
| Abbvie INC. | $336.26 | 2021-2022 | |
| Coopersurgical, INC. | $335.45 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Shield Therapeutics INC | $206.67 | 2023-2025 | Accrufer |
| Daiichi Sankyo INC. | $183.25 | 2021-2025 | Injectafer |
| Biogen, INC. | $175.05 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $165.36 | 2021-2022 | |
| Exeltis, USA INC. | $114.20 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $88.79 | 2024-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $72.63 | 2022-2024 | |
| Mylan Pharmaceuticals INC. | $72.33 | 2021 | |
| Hologic Sales and Service, LLC | $45.58 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $43.41 | 2023-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $37.19 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $36.74 | 2025 | Nexplanon |
| Millicent US INC | $23.00 | 2025 | Femlyv |
| Exact Sciences Corporation | $22.81 | 2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $18.41 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Steinfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.